DD
Therapeutic Areas
lupin Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Sugammadex Injection | Neuromuscular blockade reversal | Approved (Tentative) |
| Pitolisant Tablets | Narcolepsy | Approved (Tentative) |
| Semaglutide Injection | Type 2 Diabetes, Obesity | Market |
| Novel GLP-1 Receptor Agonist | Metabolic Disorders | Pre-clinical/Clinical |
| Biosimilars Portfolio | Oncology, Immunology | Various |
| Plasil® | Gastroenterology | Market |